Chronic ΔFosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy

Molecular Brain Research

Volumn 79, Issue 1-2, 2000, Pages 138-149

  Morris, T Allen ^a   Jafari, Neda ^a   Delorenzo, Robert J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1; DeltaFosB; Epilepsy; Neuronal plasticity; Pilocarpine; Serum response factor; Status epilepticus

Indexed keywords

BRAIN PROTEIN; PILOCARPINE; PROTEIN B FOS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN C FOS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; EPILEPSY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; ELECTRIC SHOCK; GENETICS; LONG TERM POTENTIATION; METABOLISM; NERVE CELL; ONCOGENE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURE; SPRAGUE DAWLEY RAT; TEMPORAL LOBE EPILEPSY;

ANIMALS; ELECTROSHOCK; EPILEPSY, TEMPORAL LOBE; GENES, FOS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURONS; PILOCARPINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; TRANSCRIPTION FACTOR AP-1;

EID: 0034705573     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00112-1     Document Type: Article

References (42)

1. Bing G., Wilson B., Hudson P., Jin L., Feng Z., Zhang W., Bing R., Hong J.S. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9422-9427.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. DeLorenzo R.J. The challenging genetics of epilepsy. Epilepsy Res. Suppl. 4:1991;3-17.
4. DeLorenzo R.J., Morris T.A. Long-term modulation of gene expression in epilepsy. The Neuroscientist. 5:1999;86-99.
5. DeLorenzo R.J., Pal S., Sombati S. Prolonged activation of the NMDA receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14482-14487.
6. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
7. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3720-3724.
8. Hauser W.A., Hesdorffer D.C. Epilepsy: Frequency, Causes and Consequences. 1990;Demos Publications, New York.
9. Herdegen T., Kovary K., Buhl A., Bravo R., Zimmermann M., Gass P. Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain. J. Comp. Neurol. 354:1995;39-56.
10. Hiroi N., Marek G.J., Brown J.R., Ye H., Saudou F., Vaidya V.A., Duman R.S., Greenberg M.E., Nestler E.J. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J. Neurosci. 18:1998;6952-6962.
11. Hope B.T., Kelz M.B., Duman R.S., Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14:1994;4318-4328.
12. Kang I., Lindquist D.G., Kinane T.B., Ercolani L., Pritchard G.A., Miller L.G. Isolation and characterization of the promoter of the human GABAA receptor alpha 1 subunit gene. J. Neurochem. 62:1994;1643-1646.
13. Kelz M.B., Chen J., Carlezon W.A.J., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
14. Kim Y., Glatt H., Xie W., Sinnett D., Lalande M. Human gamma-aminobutyric acid-type A receptor alpha5 subunit gene (GABRA5): characterization and structural organization of the 5′ flanking region. Genomics. 42:1997;378-387.
15. Lazo P.S., Dorfman K., Noguchi T., Mattei M.G., Bravo R. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter. Nucleic Acids Res. 20:1992;343-350.
16. Leite J.P., Cavalheiro E.A. Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res. 20:1995;93-104.
17. Lothman E.W., Bertram E.H. Epileptogenic effects of status epilepticus. Epilepsia. 34:(Suppl. 1):1993;S59-S70.
18. Malenka R.C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 78:1994;535-538.
19. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa fos-related antigen and AP-1 like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 17:1997;5407-5415.
20. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
21. Mello L.E., Cavalheiro E.A., Tan A.M., Kupfer W.R., Pretorius J.K., Babb T.L., Finch D.M. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia. 34:1993;985-995.
22. Mello L.E., Kohman C.M., Tan A.M., Cavalheiro E.A., Finch D.M. Lack of Fos-like immunoreactivity after spontaneous seizures or reinduction of status epilepticus by pilocarpine in rats. Neurosci. Lett. 208:1996;133-137.
23. Moore A.N., Waxham M.N., Dash P.K. Neuronal activity increases the phosphorylation of the transcription factor cAMP response element-binding protein (CREB) in rat hippocampus and cortex. J. Biol. Chem. 271:1996;14214-14220.
24. Morgan J.I., Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci. 12:1991;343-349.
25. Morris T.A., Jafari N., Rice A.C., Vasconcelos O., DeLorenzo R.J. Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes. J. Neurosci. 19:1999;8234-8243.
26. Nestler E.J., Kelz M.B., Chen J. DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res. 835:1999;10-17.
27. Ormandy G.C., Jope R.S., Snead O.C. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp. Neurol. 106:1989;172-180.
28. Pal S., Sombati S., DeLorenzo R.J. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res. 851:1999;20-31.
29. Pennypacker K. AP-1 transcription factors: short- and long-term modulators of gene expression in the brain. Int. Rev. Neurobiol. 42:1998;169-197.
30. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferferg H.J., Scoville B., White B.G. Antiepileptic drug development program. Cleve. Clin. Q. 51:1984;293-305.
31. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
32. Rice A., Rafiq A., Shapiro S.M., Jakoi E.R., Coulter D.A., DeLorenzo R.J. Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9665-9669.
33. Rice A.C., DeLorenzo R.J. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782:1998;240-247.
34. Sanabria E.R., Scorza F.A., Bortolotto Z.A., Calderazzo-Filho L.S., Cavalheiro E.A. Disruption of light-induced c-Fos immunoreactivity in the suprachiasmatic nuclei of chronic epileptic rats. Neurosci. Lett. 216:1996;105-108.
35. Schmidt D. The influence of antiepileptic drugs on the electroencephalogram: a review of controlled clinical studies. Electroencephalogr. Clin. Neurophysiol. Suppl. 36:1982;453-466.
36. Sombati S., DeLorenzo R.J. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73:1995;1706-1711.
37. Spencer J.A., Misra R.P. Expression of the serum response factor gene is regulated by serum response factor binding sites. J. Biol. Chem. 271:1996;16535-16543.
38. Stafstrom C.E., Holmes G.L., Thompson J.L. MK801 pretreatment reduces kainic acid-induced spontaneous seizures in prepubescent rats. Epilepsy Res. 14:1993;41-48.
39. Stafstrom C.E., Thompson J.L., Holmes G.L. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Dev. Brain Res. 65:1992;227-236.
40. Stasheff S.F., Anderson W.W., Clark S., Wilson W.A. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science. 245:1989;648-651.
41. Trujillo K.A., Akil H. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38:1995;139-154.
42. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9:1983;315-335.